Correction to: A multicentre, multi-national, double-blind, randomised, active-controlled, parallel-group clinical study to assess the safety and efficacy of PDA10 (Epoetin-Alfa) vs. Eprex® in patients with anaemia of chronic renal failure
Crossref DOI link: https://doi.org/10.1186/s12882-021-02651-0
Published Online: 2022-01-03
Published Print: 2022-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Lim, Soo Kun
Goh, Bak Leong
Visvanathan, Ravindran
Kim, Su Hyun
Jeon, Jin Seok
Kim, Sung Gyun
Chang, Jae Hyun
Lim, Chun Soo
Morad, Zaki
Text and Data Mining valid from 2022-01-03
Version of Record valid from 2022-01-03
Article History
First Online: 3 January 2022